Pacific Edge's revenue climbs, US future still uncertain

Pacific Edge's revenue climbs, US future still uncertain
Very strong revenue growth, but profit still some distance away (Image: Pacific Edge)
Ella Somers
A boom in Pacific Edge’s Cxbladder test sales boosted the firm’s operating revenue soar by 71%, with a helping hand from favourable exchange rates.Chief executive Peter Meintjes said the 2023 financial year had been a year of “enormous change and achievement” for the cancer diagnostic company.“Pacific Edge is geared for growth,” he told the NZX.Operating revenue for the twelve months to March 31 rose $19.6 million, up from $11.4m in the previous year while total revenue jumped 88% to $26.1m.The revenue climb...

More Markets

Gentrack leads NZ sharemarket down almost 1%
Markets Market Close

Gentrack leads NZ sharemarket down almost 1%

The S&P/NZX 50 Index closed at 12,225.28, down 113.29 points or 0.92%.

Graham Skellern 04 Apr 2025
Takeovers Panel will meet on NZME issue
Markets

Takeovers Panel will meet on NZME issue

The panel said in a media release today it had met on the issue of Grenon’s shareholding.

Staff reporters 04 Apr 2025
Asian stocks extend global rout
Markets

Asian stocks extend global rout

Tokyo shares fall as Trump predicts a coming US boom.

AFP 04 Apr 2025